Okupe Oluyemi's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Sep 30, 2025
- Accession no.
- 0001773751-25-000327
- Filed
- Sep 30, 2025
- Trade date
- Sep 29, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.12M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Okupe OluyemiCIK 0001907056 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | Class A Common Stock | MOption exerciseAcquired | +49,832 | $5.01 | +$249,658.32 | 155,232 | Direct | |
| Sep 29, 2025 | Class A Common Stock | SSaleDisposed | −85,000 | $60.20F2 | −$5,117,000 | 70,232 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 29, 2025 | Class A Common Stock | MOption exerciseDisposed | −49,832 | $0.00 | $0 | 189,952 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $59.95 - $60.48. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.